Home
/
Poland
/
Clone Robotics

Clone Robotics

Clone Robotics develops musculoskeletal, biomimetic androids with human-level dexterity and artificial muscles for versatile daily tasks and industrial use.
Legal Name
This is some text inside of a div block.
Founded
Jan 2021
Company Type
Private
Company Size
11 - 50
Address
Poland
No items found.
Presence in Countries
No items found.
Founding Country
Poland
IPO Date
Stock Symbol
Leadership
-
Astralis Awards
-

Intro

Clone Robotics is a Polish startup pioneering the development of superintelligent, musculoskeletal androids that closely mimic human anatomy and motion. Their robots feature proprietary artificial muscle technology ("Myofibers"), pneumatic and hydraulic actuation, and a biomimetic skeletal system with over 200 degrees of freedom. Clone’s flagship androids, such as Protoclone and Alpha, demonstrate lifelike motion, dexterity, and strength, powered by compact hydraulic systems and advanced control algorithms. The company aims to commercialize humanoid robots capable of performing complex tasks safely and efficiently in both consumer and industrial environments. Clone Robotics has raised $6.5 million in seed funding and is currently accepting pre-orders for beta products like the Clone Hand and Clone Torso.

Key Achievement:In December 2024, Clone unveiled Alpha, a humanoid prototype that walks using soft, water-powered artificial muscles, marking a breakthrough in biomimetic robot mobility and control.

Robots

  • clone@clonerobotics.comClone Alpha: The world’s most anatomically accurate robot, featuring over 1,000 artificial muscles, 500 sensors, and a full human skeletal framework with articulated joints and ligaments. It offers more than 200 degrees of freedom and lifelike motion powered by pneumatic systems, with plans to upgrade to hydraulics.
  • Clone Torso 2: A bimanual android torso with actuated lumbar spine and abdominal muscles, 164 degrees of freedom, and 182 sensors, capable of complex upper-body movements and manipulation.
  • Clone Hand: A durable, 27 degree-of-freedom robotic hand with human-level dexterity, capable of grasping virtually any object, currently entering production.

Specialism

  • Biomimetic design replicating human musculoskeletal, vascular, and nervous systems.
  • Proprietary artificial muscle technology ("Myofibers") enabling soft, fluid, and powerful movements.
  • Compact hydraulic and pneumatic actuation systems for precise force control.
  • High degrees of freedom (200+) for natural, humanlike motion and dexterity.
  • Integration of hundreds of sensors for feedback and control.
  • Focus on commercial deployment beyond research prototypes.

Business Viability

  • Raised $6.5 million in seed funding to advance R&D and production.
  • Strong interdisciplinary team with expertise in robotics, hydraulics, AI, and biomechanics.
  • Active pre-orders for beta products to validate market demand and refine technology.
  • Positioned as a leader in biomimetic humanoid robotics with unique muscle-based actuation.
  • Plans to transition from pneumatic to hydraulic systems for enhanced performance and quieter operation.
  • Targeting applications in household assistance, industry, healthcare, and research.